ReviewArchives of virology2025
NK and T cell evasion mechanism of human cytomegalovirus.
Review in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mechanisms and Determinants of CMV Reactivation in Kidney Transplantation.International journal of molecular sciences · 2026Review
- Clinical Characteristics and Outcomes of Cytomegalovirus DNAemia in Non-HIV-Infected and Non-Transplant Patients: A Propensity Score-Matched Analysis.Pathogens (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human cytomegalovirus (HCMV) is a betaherpesvirus that has evolved multiple defense mechanisms against host immunity. Most HCMV infections go unnoticed, but the reactivation of the latent virus can be life-threatening in immune-suppressed people. Over millions of years of coevolution with the human host, HCMV has adapted to evade both innate and adaptive immune responses through a dynamic host-pathogen arms race in which selective pressures from host immunity have driven the diversification and refinement of viral genes. This is particularly evident in the UL and US regions of the HCMV genome, which encode multiple proteins that interfere with antigen presentation and modulate immune receptor signaling. HCMV also employs molecular mimicry, encoding an MHC class I homolog, UL18, which binds to LIR-1 to inhibit NK cell activation, enabling immune evasion and persistent infection. This mini-review focuses on the key immunoevasive mechanisms by which HCMV gene products interfere with NK and T cell recognition and effector functions to modulate host immune responses. Elucidating these strategies is critical for identifying novel antiviral targets and informing the rational design of effective vaccines.
Indexed as
Identifiers
41214228What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.